Samantha Scollard Truex
Independent DirectorMs. Samantha Scollard Truex, also known as Sam, is CEO & Director of Oblenio Bio, Inc. Ms. Truex served as Chief Executive Officer, President and Director at Upstream Bio Inc. Ms. Truex serves as Venture Partner at Atlas Venture Advisors, Inc. (formerly known as Atlas Venture L.P.). since joining on May 10, 2021. She is Board Chair of Artios Pharma Limited from June 2025. Ms. Truex was Director of Artios Pharma Limited from 2022 to June 2025. She works with the Atlas team to start and build new biotech companies aimed at bringing therapeutic innovations to patients. She served as Director at HotSpot Therapeutics, Inc. until 2022. She served as Chief Executive Officer, President and Director at Quench Bio, Inc. She has been appointed chair of Thayer School’s board of advisors. She joined Thayer’s board in 2015. She previously served on the corporate collaboration council advising Thayer’s MEM program. Ms. Truex served as Chief Operating Officer and Head of Corporate Development at Synlogic, Inc. since December 15, 2016. She joined Synlogic with industry experience. Ms. Truex served as the Chief Business Officer of Padlock Therapeutics, Inc. since 2014. At Biogen Idec, she served as Vice President in the Corporate Development Group and also served as Program Lead for multiple preclinical and launch-stage products. She led licensing and M&A transactions across multiple business units of Genzyme. She has experience in the biotech industry. She was a program executive of FAMPYRA® during its launch phase and of ELOCTATE™ and ALPROLIX™ during the preclinical and early clinical phases. Ms. Truex is active in developing future biotech leadership talent through her creation of the Teton Biotech Mini-Internship. She worked for Chiron Diagnostics and Health Advances. She earned a B.A. from Dartmouth College in Biology and Engineering from 1988 to 1992, a B.E. in biomedical engineering from the Thayer School of Engineering at Dartmouth from 1993 to 1993 and an MBA from the Tuck School of Business at Dartmouth from 1993 to 1995. Ms. Truex serves as an Independent Director at Avalo Therapeutics, Inc. since March 2024.
Positions
- Company NameAvalo Therapeutics, Inc.Stock CodeAVTXPositionIndependent DirectorColleagues
- GAGarry A. NeilPresident, CEO & Director
- MTMichael Thomas HeffernanIndependent Chairman of the Board
- MDMittie DoyleChief Medical Officer
- TBTaylor BoydChief Business Officer
- SHSolomon H. SnyderFounder and Chairman of Scientific Advisory Board
- BSBarbara S. SlusherFounder and Member of Scientific Advisory Board
